Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37538124 | PubTator, text mining | PubMed |
| Population-level antagonism between FGF and BMP signaling steers mesoderm differentiation in embryonic stem cells. | Biol Open | 2023 | 37530863 | PubTator, text mining | PubMed |
| Reproducible generation of human retinal ganglion cells from banked retinal progenitor cells: analysis of target recognition and IGF-1-mediated axon regeneration. | Front Cell Dev Biol | 2023 | 37519299 | PubTator, text mining | PubMed |
| From the Discovery of Targets to Delivery Systems: How to Decipher and Improve the Metallodrugs' Actions at a Molecular Level. | Pharmaceutics | 2023 | 37514183 | PubTator, text mining | PubMed |
| Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37511133 | PubTator, text mining | PubMed |
| Retracted: Fibroblast Growth Factor 3 Is Associated with Tongue Squamous Cell Carcinoma: A Controlled Study. | Comput Math Methods Med | 2023 | 37503431 | PubTator, text mining | PubMed |
| Therapeutic resistance to anti-oestrogen therapy in breast cancer. | Nat Rev Cancer | 2023 | 37500767 | PubTator, text mining | PubMed |
| Fibroblast growth factor 3 promotes spontaneous mammary tumorigenesis in Tientsin albino 2 mice via the FGF3/FGFR1/STAT3 pathway. | Front Oncol | 2023 | 37496658 | PubTator, text mining | PubMed |
| Current progress in cancer treatment by targeting FGFR signaling. | Cancer Biol Med | 2023 | 37493315 | PubTator, text mining | PubMed |
| Molecular mechanisms controlling vertebrate retinal patterning, neurogenesis, and cell fate specification. | Trends Genet | 2023 | 37423870 | PubTator, text mining | PubMed |
| Etiology of super-enhancer reprogramming and activation in cancer. | Epigenetics Chromatin | 2023 | 37415185 | PubTator, text mining | PubMed |
| Nuclear Resonance Vibrational Spectroscopy Definition of Peroxy Intermediates in Catechol Dioxygenases: Factors that Determine Extra- versus Intradiol Cleavage. | J Am Chem Soc | 2023 | 37414058 | PubTator, text mining | PubMed |
| Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine. | Cells | 2023 | 37408278 | PubTator, text mining | PubMed |
| PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system. | NPJ Precis Oncol | 2023 | 37400502 | PubTator, text mining | PubMed |
| Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma. | World J Virol | 2023 | 37396703 | PubTator, text mining | PubMed |
| Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors. | Oncologist | 2023 | 37390492 | PubTator, text mining | PubMed |
| Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice. | Cell Rep | 2023 | 37389991 | PubTator, text mining | PubMed |
| The Protective Role of Cranberries and Blueberries in Oral Cancer. | Plants (Basel) | 2023 | 37375955 | PubTator, text mining | PubMed |
| Bacterial Communities Associated with Houseflies (Musca domestica L.) Inhabiting Hospices in South Africa. | Microorganisms | 2023 | 37374941 | PubTator, text mining | PubMed |
| The spontaneous mouse mutant low set ears (Lse) is caused by tandem duplication of Fgf3 and Fgf4. | Mamm Genome | 2023 | 37341808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=9